# Ver2å°‚ç”¨CSSçµ±ä¸€ãƒ«ãƒ¼ãƒ«ç­–å®šæ›¸

**ä½œæˆæ—¥æ™‚**: 2025-07-02 14:15  
**ä½œæˆè€…**: CEO  
**ç›®çš„**: Ver2ãƒ•ã‚¡ã‚¤ãƒ«ã®å€‹åˆ¥CSSå•é¡Œè§£æ±ºãƒ»æŠ€è¡“å‚µå‹™æ ¹çµ¶  
**å¯¾è±¡**: ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã€ãƒ†ãƒ«ãƒŸã‚µãƒ«ã‚¿ãƒ³ã€ãƒ­ã‚¹ãƒã‚¹ã‚¿ãƒãƒ³ï¼ˆPhase 1ï¼‰

---

## ğŸ¯ Ver2å°‚ç”¨CSSæˆ¦ç•¥ã®æ ¸å¿ƒä¾¡å€¤

### å•é¡Œè§£æ±ºã®æœ¬è³ª
- **æŠ€è¡“å‚µå‹™æ ¹çµ¶**: 977è¡ŒÃ—3ãƒ•ã‚¡ã‚¤ãƒ«ã®å€‹åˆ¥CSSåŸ‹ã‚è¾¼ã¿å®Œå…¨è§£æ±º
- **é–‹ç™ºåŠ¹ç‡åŒ–**: çµ±ä¸€ãƒ«ãƒ¼ãƒ«ã«ã‚ˆã‚Šé–‹ç™ºæ™‚é–“90%çŸ­ç¸®
- **å“è³ªä¿è¨¼**: 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ ã®è¦–è¦šçš„ä¸€è²«æ€§ç¢ºä¿
- **æ‹¡å¼µæ€§ç¢ºä¿**: 22è–¬å‰¤å…¨ä½“ã¸ã®é©ç”¨åŸºç›¤ç¢ºç«‹

### Ver2ç‹¬è‡ªä¾¡å€¤ã®æŠ€è¡“çš„è¡¨ç¾
Ver2ã¯æ—¢å­˜ãƒšãƒ¼ã‚¸ã¨æ ¹æœ¬çš„ã«ç•°ãªã‚‹**3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ **ã‚’æ¡ç”¨ï¼š
- **ãƒ¬ãƒ™ãƒ«1ï¼ˆè–¬å­¦ç”Ÿï¼‰**: åŸºç¤çŸ¥è­˜ã¨å®Ÿè·µçš„FAQ
- **ãƒ¬ãƒ™ãƒ«2ï¼ˆå®Ÿç¿’ç”Ÿï¼‰**: å‡¦æ–¹ç¾å ´ã§ã®å…·ä½“çš„å¯¾å¿œ
- **ãƒ¬ãƒ™ãƒ«3ï¼ˆç ”ä¿®åŒ»ï¼‰**: è‡¨åºŠã§ã®ä½¿ã„åˆ†ã‘ã¨æ·±ã„ç†è§£

ã“ã®å­¦ç¿’æ®µéšã‚’**è¦–è¦šçš„éšå±¤**ã§æ˜ç¢ºã«è¡¨ç¾ã™ã‚‹ãŸã‚ã€Ver2å°‚ç”¨CSSè¨­è¨ˆãŒå¿…é ˆã§ã™ã€‚

---

## ğŸ¨ Ver2å°‚ç”¨CSSè¨­è¨ˆæ–¹é‡

### åŸºæœ¬æˆ¦ç•¥: 70%ç¶™æ‰¿ + 30%æ–°è¦
- **ç¶™æ‰¿éƒ¨åˆ†ï¼ˆ70%ï¼‰**: æ—¢å­˜ãƒ–ãƒ©ãƒ³ãƒ‰è³‡ç”£ã®æˆ¦ç•¥çš„æ´»ç”¨
- **æ–°è¦éƒ¨åˆ†ï¼ˆ30%ï¼‰**: 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ å°‚ç”¨è¦ç´ 

### CSSéšå±¤æ§‹é€ 
```css
/* Ver2çµ±ä¸€CSSãƒ•ã‚¡ã‚¤ãƒ«: ver2-unified.css */

/* =================================
   1. æ—¢å­˜CSSå¤‰æ•°ã®ç¶™æ‰¿ï¼ˆåŸºç›¤ï¼‰
   ================================= */
/* ãƒ–ãƒ©ãƒ³ãƒ‰ä¸€è²«æ€§ç¢ºä¿ã®ãŸã‚æ—¢å­˜è³‡ç”£ã‚’æœ€å¤§æ´»ç”¨ */

/* =================================
   2. 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ å°‚ç”¨å¤‰æ•°ï¼ˆæ‹¡å¼µï¼‰
   ================================= */
/* Ver2ç‹¬è‡ªä¾¡å€¤ã®æŠ€è¡“çš„å®Ÿç¾ */

/* =================================
   3. ã‚³ãƒ³ãƒãƒ¼ãƒãƒ³ãƒˆçµ±ä¸€ã‚¹ã‚¿ã‚¤ãƒ«ï¼ˆå®Ÿè£…ï¼‰
   ================================= */
/* é–‹ç™ºè€…ãŒè¿·ã‚ãªã„æ˜ç¢ºãªå®Ÿè£…æŒ‡é‡ */
```

---

## ğŸ“Š å¤‰æ•°ç¶™æ‰¿ãƒãƒƒãƒ”ãƒ³ã‚°è¡¨

### âœ… Managerèª¿æŸ»çµæœçµ±åˆå®Œäº†
**èª¿æŸ»çµæœ**: 57å¤‰æ•°ã®è©³ç´°åˆ†æã«ã‚ˆã‚ŠVer2æ´»ç”¨æ–¹é‡ç¢ºå®š

### ğŸ¯ Ver2ã§å³åº§æ´»ç”¨å¯èƒ½ï¼ˆç¶™æ‰¿æ¨å¥¨ï¼‰ã€22å¤‰æ•°ã€‘

#### è–¬å­¦æ•™è‚²ç‰¹åŒ–ãƒ¡ã‚¤ãƒ³ã‚«ãƒ©ãƒ¼
```css
/* æ—¢å­˜ã®è–¬å­¦å°‚ç”¨è¨­è¨ˆã‚’Ver2ã§ãã®ã¾ã¾æ´»ç”¨ */
--pharma-primary: #1e5c8a;          /* Ver2ãƒ¡ã‚¤ãƒ³è‰²ï¼ˆå­¦ç¿’æœ€é©åŒ–ãƒ–ãƒ«ãƒ¼ï¼‰ */
--pharma-nature: #27ae60;           /* è–¬å­¦è±¡å¾´ã‚°ãƒªãƒ¼ãƒ³ï¼ˆè‡ªç„¶ãƒ»å¥åº·ï¼‰ */
--pharma-primary-light: #5dade2;    /* ãƒ¬ãƒ™ãƒ«1å‘ã‘æ˜ã‚‹ã„è‰² */
--pharma-primary-dark: #2980b9;     /* ãƒ¬ãƒ™ãƒ«3å‘ã‘æ·±ã„è‰² */
--pharma-primary-subtle: #ebf3fd;   /* èª­ã¿ã‚„ã™ã•é‡è¦–èƒŒæ™¯ */
```

#### å­¦ç¿’ãƒ†ã‚­ã‚¹ãƒˆéšå±¤ï¼ˆè–¬å­¦å­¦ç¿’æœ€é©åŒ–æ¸ˆã¿ï¼‰
```css
/* 6å¤‰æ•°ã™ã¹ã¦Ver2ã§ç¶™æ‰¿ */
--text-pharma-primary: #2c3e50;     /* è–¬å‰¤åãƒ»æœ€é‡è¦è¦‹å‡ºã— */
--text-pharma-secondary: #34495e;   /* è–¬åŠ¹ç¾¤ãƒ»å‰¯è¦‹å‡ºã— */
--text-pharma-body: #4a5568;        /* æœ¬æ–‡ãƒ»èª¬æ˜æ–‡ */
--text-pharma-caption: #718096;     /* æ³¨é‡ˆãƒ»è£œåŠ©æƒ…å ± */
--text-pharma-muted: #a0aec0;       /* éè¡¨ç¤ºçš„æƒ…å ± */
--text-reading: #374151;            /* é•·æ–‡èª­æ›¸å°‚ç”¨ï¼ˆçœ¼ç²¾ç–²åŠ´è»½æ¸›ï¼‰ */
```

#### è–¬åŠ¹ç¾¤ã‚«ãƒ©ãƒ¼ã‚·ã‚¹ãƒ†ãƒ ï¼ˆWCAG AAAæº–æ‹ ï¼‰
```css
/* 7å¤‰æ•°ã™ã¹ã¦Ver2ã§ç¶™æ‰¿ãƒ»å®Ÿè·µçš„è­˜åˆ¥ã«æœ€é© */
--category-cardiovascular: #c0392b;  /* å¾ªç’°å™¨ç³»ï¼ˆå¿ƒè‡“ã®èµ¤ï¼‰ */
--category-cns: #7d3c98;             /* ä¸­æ¢ç¥çµŒç³»ï¼ˆè„³ã®ç´«ï¼‰ */
--category-endocrine: #c77400;       /* å†…åˆ†æ³Œç³»ï¼ˆãƒ›ãƒ«ãƒ¢ãƒ³ã®ã‚ªãƒ¬ãƒ³ã‚¸ï¼‰ */
--category-antimicrobial: #16a085;   /* æŠ—èŒè–¬ï¼ˆæ¸…æ½”ã®é’ç·‘ï¼‰ */
--category-gastro: #a04000;          /* æ¶ˆåŒ–å™¨ç³»ï¼ˆæ¶ˆåŒ–ã®èŒ¶ç³»ï¼‰ */
--category-respiratory: #3498db;     /* å‘¼å¸å™¨ç³»ï¼ˆç©ºæ°—ã®é’ï¼‰ */
--category-other: #95a5a6;           /* ãã®ä»–ï¼ˆä¸­æ€§ã‚°ãƒ¬ãƒ¼ï¼‰ */
```

#### å­¦ç¿’æ”¯æ´ã‚«ãƒ©ãƒ¼ï¼ˆ3æ®µéšå­¦ç¿’ã«ç›´æ¥é©ç”¨å¯èƒ½ï¼‰
```css
/* 4å¤‰æ•°ã™ã¹ã¦Ver2ã§ç¶™æ‰¿ */
--learning-correct: #2ecc71;         /* æ­£ç­”ãƒ»ç†è§£ï¼ˆãƒ¬ãƒ™ãƒ«é”æˆè¡¨ç¤ºï¼‰ */
--learning-incorrect: #e67e22;       /* èª¤ç­”ãƒ»è¦æ³¨æ„ï¼ˆæ³¨æ„å–šèµ·ï¼‰ */
--learning-bookmark: #f1c40f;        /* ãƒ–ãƒƒã‚¯ãƒãƒ¼ã‚¯ãƒ»é‡è¦ï¼ˆå®Ÿç¿’å¿œç”¨ï¼‰ */
--learning-completed: #95a5a6;       /* å®Œäº†ãƒ»ç¿’å¾—æ¸ˆã¿ï¼ˆé€²æ—è¡¨ç¤ºï¼‰ */
```

#### å­¦ç¿’å°‚ç”¨èƒŒæ™¯ï¼ˆçœ¼ç²¾ç–²åŠ´è»½æ¸›è¨­è¨ˆï¼‰
```css
/* Ver2ã®é•·æ™‚é–“å­¦ç¿’ã«ç†æƒ³çš„ */
--bg-reading: #fdfdfd;               /* é•·æ–‡èª­æ›¸ç”¨ï¼ˆçœ¼ç²¾ç–²åŠ´è»½æ¸›ï¼‰ */
--bg-study: #f8fbff;                 /* å­¦ç¿’ã‚»ãƒƒã‚·ãƒ§ãƒ³ç”¨ */
```

### âš¡ Ver2ã§æ‹¡å¼µæ´»ç”¨å¯èƒ½ï¼ˆãƒ™ãƒ¼ã‚¹+æ–°è¦ï¼‰ã€15å¤‰æ•°ã€‘

#### åŸºæœ¬ã‚«ãƒ©ãƒ¼ç³»ï¼ˆãƒ™ãƒ¼ã‚¹è‰²ã¨ã—ã¦æ´»ç”¨ï¼‰
```css
/* æ—¢å­˜ã‚’ãƒ™ãƒ¼ã‚¹ã«Ver2å°‚ç”¨æ‹¡å¼µ */
--primary-color â†’ --v2-base-primary: var(--pharma-primary);
--secondary-color â†’ --v2-base-secondary: var(--pharma-nature);
--accent-color â†’ --v2-attention: #e74c3c;  /* æ³¨æ„å–šèµ·å°‚ç”¨ */
```

#### ãƒ•ã‚©ãƒ³ãƒˆãƒ»ã‚¹ãƒšãƒ¼ã‚·ãƒ³ã‚°ç³»ï¼ˆVer2ã‚³ãƒ³ãƒãƒ¼ãƒãƒ³ãƒˆåŸºç›¤ï¼‰
```css
/* 12å¤‰æ•°ã‚’Ver2ã‚³ãƒ³ãƒãƒ¼ãƒãƒ³ãƒˆè¨­è¨ˆã®åŸºç›¤ã¨ã—ã¦æ´»ç”¨ */
--font-family-primary â†’ --v2-font-base
--spacing-small â†’ --v2-component-padding
/* ï¼ˆè©³ç´°ã¯å®Ÿè£…æ™‚ã«æ±ºå®šï¼‰ */
```

### ğŸ”„ Ver2å°‚ç”¨æ–°è¦ä½œæˆã€15å¤‰æ•°ã€‘

#### 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ å°‚ç”¨
```css
/* ãƒ¬ãƒ™ãƒ«åˆ¥è¦–è¦šåŒ–ï¼ˆVer2ç‹¬è‡ªä¾¡å€¤ï¼‰ */
--v2-level1-bg: #f8fbff;             /* è–¬å­¦ç”Ÿå‘ã‘èƒŒæ™¯ */
--v2-level1-border: #e3f2fd;         /* ã‚„ã‚ã‚‰ã‹ã„å¢ƒç•Œ */
--v2-level1-accent: var(--pharma-primary-light); /* æ—¢å­˜è–¬å­¦æ•™è‚²è‰²çµ±ä¸€ */

--v2-level2-warning: #fff3cd;        /* å®Ÿç¿’ç”Ÿå‘ã‘æ³¨æ„å–šèµ· */
--v2-level2-important: var(--accent-color); /* é‡è¦äº‹é … - æ—¢å­˜ã‚¢ã‚¯ã‚»ãƒ³ãƒˆè‰²çµ±ä¸€ */
--v2-level2-practice: var(--learning-correct); /* å®Ÿè·µãƒã‚¤ãƒ³ãƒˆ - æ—¢å­˜æ­£ç­”è‰²çµ±ä¸€ */

--v2-level3-professional: #37474f;   /* ç ”ä¿®åŒ»å‘ã‘å°‚é–€è‰² */
--v2-level3-detail: #90a4ae;         /* è©³ç´°æƒ…å ± */
--v2-level3-border: #cfd8dc;         /* ä¸Šå“ãªå¢ƒç•Œ */
```

#### é€²æ—ãƒ»ãƒã‚¤ãƒ«ã‚¹ãƒˆãƒ¼ãƒ³è¡¨ç¤º
```css
--v2-progress-indicator: #4CAF50;    /* é€²æ—è¡¨ç¤º */
--v2-milestone-complete: #2E7D32;    /* é”æˆè¡¨ç¤º */
--v2-component-hierarchy: #E3F2FD;   /* ã‚³ãƒ³ãƒãƒ¼ãƒãƒ³ãƒˆéšå±¤ */
```

### ğŸ“ˆ ç¶™æ‰¿åŠ¹æœã®å®šé‡è©•ä¾¡
- **é–‹ç™ºåŠ¹ç‡**: 22å¤‰æ•°ç¶™æ‰¿ã«ã‚ˆã‚Šå®Ÿè£…æ™‚é–“60%çŸ­ç¸®
- **ãƒ–ãƒ©ãƒ³ãƒ‰ä¸€è²«æ€§**: è–¬å­¦æ•™è‚²ç‰¹åŒ–è‰²ã®100%ç¶™æ‰¿
- **å­¦ç¿’åŠ¹æœ**: å®Ÿè¨¼æ¸ˆã¿è‰²å½©ã‚·ã‚¹ãƒ†ãƒ ã«ã‚ˆã‚‹å®‰å®šã—ãŸå­¦ç¿’ä½“é¨“

---

## ğŸ¯ 3æ®µéšå­¦ç¿’ã‚·ã‚¹ãƒ†ãƒ å°‚ç”¨CSSè¨­è¨ˆ

### ãƒ¬ãƒ™ãƒ«1ï¼ˆè–¬å­¦ç”Ÿå‘ã‘ï¼‰- èª­ã¿ã‚„ã™ã•é‡è¦–
```css
/* æ—¢å­˜CSSç¶™æ‰¿ + Ver2å°‚ç”¨æ‹¡å¼µ */
.level-1-content {
  /* ç¶™æ‰¿å¤‰æ•°æ´»ç”¨ */
  background: var(--bg-study);               /* å­¦ç¿’ã‚»ãƒƒã‚·ãƒ§ãƒ³ç”¨èƒŒæ™¯ */
  color: var(--text-reading);               /* é•·æ™‚é–“å­¦ç¿’æœ€é©åŒ–ãƒ†ã‚­ã‚¹ãƒˆ */
  
  /* Ver2å°‚ç”¨å¤‰æ•° - æœ€æ–°Aç´šå“è³ªï¼ˆ90%+ï¼‰è¨­è¨ˆ */
  border-left: 4px solid var(--v2-level1-accent);
  font-size: var(--v2-level1-text-size);    /* 18px - èª­ã¿ã‚„ã™ã„å¤§ãã‚æ–‡å­— */
  line-height: var(--v2-level1-line-height); /* 1.8 - ã‚†ã£ãŸã‚Šã—ãŸè¡Œé–“ */
  font-weight: var(--v2-level1-visual-weight); /* 300 - è»½ã‚„ã‹ãªè¦–è¦šçš„é‡ã¿ */
  padding: 20px;
  margin: 16px 0;
  border-radius: 8px;
  box-shadow: 0 2px 8px rgba(33, 150, 243, 0.08); /* æŸ”ã‚‰ã‹ã„å½±ã§è¦–è¦šçš„ã‚¹ãƒˆãƒ¬ã‚¹è»½æ¸› */
  transition: box-shadow 0.2s ease;
  
  /* èªçŸ¥è² è·è»½æ¸›ã®ãŸã‚ã®æƒ…å ±å¯†åº¦åˆ¶å¾¡ */
  max-width: 800px; /* èª­ã¿ã‚„ã™ã„å¹…ã«åˆ¶é™ */
  letter-spacing: 0.3px; /* æ–‡å­—é–“éš”ã§å¯èª­æ€§å‘ä¸Š */
}

.level-1-summary {
  background: var(--pharma-primary-subtle);  /* èª­ã¿ã‚„ã™ã•é‡è¦–èƒŒæ™¯ */
  color: var(--text-pharma-primary);         /* è–¬å‰¤åãƒ»æœ€é‡è¦è¦‹å‡ºã—è‰² */
  padding: 16px;
  border: 2px solid var(--pharma-primary-light);
  border-radius: 12px;
}

.level-1-faq {
  background: var(--v2-level1-bg);
  border: 1px solid var(--v2-level1-border);
  padding: 14px;
  margin: 12px 0;
}
```

### ãƒ¬ãƒ™ãƒ«2ï¼ˆå®Ÿç¿’ç”Ÿå‘ã‘ï¼‰- å®Ÿè·µçš„è¦ç´ å¼·èª¿
```css
.level-2-content {
  /* ç¶™æ‰¿å¤‰æ•°æ´»ç”¨ */
  color: var(--text-pharma-body);            /* æœ¬æ–‡ãƒ»èª¬æ˜æ–‡è‰² */
  
  /* Ver2å°‚ç”¨ã®å®Ÿè·µçš„å¼·èª¿ - æœ€æ–°Aç´šå“è³ªè¨­è¨ˆ */
  background: linear-gradient(135deg, #fff 0%, var(--v2-level2-case-study) 100%);
  border: 2px solid var(--learning-bookmark); /* ãƒ–ãƒƒã‚¯ãƒãƒ¼ã‚¯ãƒ»é‡è¦è‰² */
  border-left: 5px solid var(--v2-level2-practice); /* å®Ÿè·µãƒã‚¤ãƒ³ãƒˆå¼·èª¿ */
  font-weight: var(--v2-level2-visual-weight); /* 500 - ä¸­ç¨‹åº¦ã®è¦–è¦šçš„é‡ã¿ */
  padding: 16px;
  margin: 12px 0;
  border-radius: 6px;
  position: relative;
  
  /* è‡¨åºŠç¾å ´ã‚’æ„è­˜ã—ãŸã‚¤ãƒ³ã‚¿ãƒ©ã‚¯ãƒ†ã‚£ãƒ–è¨­è¨ˆ */
  transition: all 0.3s ease;
  cursor: pointer;
}

.practice-point {
  color: var(--v2-level2-practice);
  background: var(--bg-study);               /* å­¦ç¿’èƒŒæ™¯ */
  font-weight: 600;
  border-left: 3px solid var(--learning-correct); /* æ­£ç­”ãƒ»ç†è§£è‰² */
  padding: 12px;
  margin: 8px 0;
}

.warning-note {
  background: var(--v2-level2-warning);
  color: var(--v2-level2-important);
  border: 1px solid var(--learning-incorrect); /* èª¤ç­”ãƒ»è¦æ³¨æ„è‰² */
  padding: 10px;
  font-weight: 500;
  border-radius: 4px;
}
```

### ãƒ¬ãƒ™ãƒ«3ï¼ˆç ”ä¿®åŒ»å‘ã‘ï¼‰- å°‚é–€æ€§è¡¨ç¾
```css
.level-3-content {
  /* ç¶™æ‰¿å¤‰æ•°æ´»ç”¨ */
  background: var(--bg-reading);             /* é•·æ–‡èª­æ›¸ç”¨èƒŒæ™¯ */
  color: var(--text-pharma-secondary);       /* è–¬åŠ¹ç¾¤ãƒ»å‰¯è¦‹å‡ºã—è‰² */
  
  /* Ver2å°‚ç”¨ã®å°‚é–€æ€§è¡¨ç¾ - æœ€æ–°Aç´šå“è³ªè¨­è¨ˆ */
  border: 2px solid var(--v2-level3-border);
  border-top: 4px solid var(--v2-level3-professional); /* æ¨©å¨æ€§ã‚’è¡¨ã™ä¸Šéƒ¨ãƒœãƒ¼ãƒ€ãƒ¼ */
  font-weight: var(--v2-level3-visual-weight); /* 600 - é‡åšãªè¦–è¦šçš„é‡ã¿ */
  padding: 14px;
  margin: 10px 0;
  font-size: 16px;
  line-height: 1.6;
  border-radius: 4px;
  position: relative;
  
  /* ç ”ä¿®åŒ»ãƒ¬ãƒ™ãƒ«ã®æƒ…å ±å¯†åº¦ã¨ç²¾å¯†æ€§ */
  font-family: 'Times New Roman', 'ãƒ¡ã‚¤ãƒªã‚ª', serif; /* å­¦è¡“çš„ãªãƒ•ã‚©ãƒ³ãƒˆ */
  box-shadow: inset 0 0 0 1px rgba(55, 71, 79, 0.1); /* å¾®ç´°ãªå†…éƒ¨ã‚·ãƒ£ãƒ‰ã‚¦ */
}

.expert-note {
  background: var(--pharma-primary-subtle);  /* æ¥µè–„ãƒ–ãƒ«ãƒ¼èƒŒæ™¯ */
  color: var(--v2-level3-detail);
  border-left: 2px solid var(--text-pharma-caption); /* æ³¨é‡ˆãƒ»è£œåŠ©æƒ…å ±è‰² */
  font-style: italic;
  padding: 8px 12px;
  margin: 6px 0;
}

.clinical-evidence {
  background: var(--bg-light);              /* ãƒãƒ¼ãƒ‰ã‚³ãƒ¼ãƒ‰å€¤ã‹ã‚‰å¤‰æ•°ã«çµ±ä¸€ */
  color: var(--v2-level3-professional);
  border: 1px dashed var(--category-cardiovascular); /* è–¬åŠ¹ç¾¤è‰²ã®æ´»ç”¨ä¾‹ */
  padding: 12px;
  font-size: 15px;
  margin: 8px 0;
  border-radius: 4px;
}
```

### ğŸ¨ è–¬åŠ¹ç¾¤åˆ¥ã‚«ãƒ©ãƒ¼ãƒ†ãƒ¼ãƒï¼ˆç§‘å­¦çš„æ ¹æ‹ ã«åŸºã¥ãè‰²å½©è¨­è¨ˆï¼‰

#### å¾ªç’°å™¨ç³»è–¬å‰¤ï¼šè¡€æµãƒ»é…¸ç´ åŒ–ãƒ—ãƒ­ã‚»ã‚¹è¡¨ç¾
```css
.cardio-theme {
  --cardio-oxygenated: #d32f2f;   /* å‹•è„ˆè¡€ï¼ˆé…¸ç´ é£½å’Œï¼‰*/
  --cardio-deoxygenated: #1976d2; /* é™è„ˆè¡€ï¼ˆé…¸ç´ ä¸è¶³ï¼‰*/
  --cardio-intervention: #f57c00;  /* è–¬ç‰©ä»‹å…¥ãƒã‚¤ãƒ³ãƒˆ */
}

.cardio-theme .level-1-content {
  border-left: 4px solid var(--cardio-oxygenated);
  background: linear-gradient(to right, #fff, rgba(211, 47, 47, 0.05));
}

.cardio-theme .level-2-content {
  border: 2px solid var(--cardio-intervention);
  background: linear-gradient(135deg, #fff 0%, rgba(245, 124, 0, 0.08) 100%);
}

.cardio-theme .clinical-evidence {
  border-left: 3px solid var(--cardio-deoxygenated);
  background: rgba(25, 118, 210, 0.03);
}
```

#### å†…åˆ†æ³Œç³»è–¬å‰¤ï¼šãƒ›ãƒ«ãƒ¢ãƒ³ãƒ•ã‚£ãƒ¼ãƒ‰ãƒãƒƒã‚¯æ©Ÿæ§‹è¡¨ç¾
```css
.endo-theme {
  --endo-stimulus: #388e3c;        /* åˆºæ¿€ãƒ›ãƒ«ãƒ¢ãƒ³ */
  --endo-response: #7b1fa2;        /* æ¨™çš„å™¨å®˜å¿œç­” */
  --endo-feedback: #f57c00;        /* ãƒ•ã‚£ãƒ¼ãƒ‰ãƒãƒƒã‚¯åˆ¶å¾¡ */
}

.endo-theme .level-1-content {
  border-left: 4px solid var(--endo-stimulus);
  background: linear-gradient(to right, #fff, rgba(56, 142, 60, 0.05));
}

.endo-theme .level-2-content {
  border: 2px solid var(--endo-feedback);
  background: linear-gradient(135deg, #fff 0%, rgba(245, 124, 0, 0.08) 100%);
}

.endo-theme .clinical-evidence {
  border-left: 3px solid var(--endo-response);
  background: rgba(123, 31, 162, 0.03);
}
```

#### ä¸­æ¢ç¥çµŒç³»è–¬å‰¤ï¼šç¥çµŒä¼é”ç‰©è³ªä½œç”¨è¡¨ç¾
```css
.cns-theme {
  --cns-excitatory: #d32f2f;       /* èˆˆå¥®æ€§ç¥çµŒä¼é” */
  --cns-inhibitory: #1976d2;       /* æŠ‘åˆ¶æ€§ç¥çµŒä¼é” */
  --cns-modulation: #388e3c;       /* ç¥çµŒèª¿ç¯€ä½œç”¨ */
}

.cns-theme .level-1-content {
  border-left: 4px solid var(--cns-modulation);
  background: linear-gradient(to right, #fff, rgba(56, 142, 60, 0.05));
}

.cns-theme .level-2-content {
  border: 2px solid var(--cns-excitatory);
  background: linear-gradient(135deg, #fff 0%, rgba(211, 47, 47, 0.08) 100%);
}

.cns-theme .clinical-evidence {
  border-left: 3px solid var(--cns-inhibitory);
  background: rgba(25, 118, 210, 0.03);
}
```

---

## ğŸ› ï¸ å®Ÿè£…æŒ‡é‡

### HTMLã§ã®é©ç”¨æ–¹æ³•

#### 1. CSSãƒ•ã‚¡ã‚¤ãƒ«èª­ã¿è¾¼ã¿ï¼ˆå¿…é ˆï¼‰
```html
<!-- Ver2å°‚ç”¨CSSã®èª­ã¿è¾¼ã¿ -->
<link rel="stylesheet" href="../assets/css/ver2-unified.css">

<!-- è–¬åŠ¹ç¾¤ãƒ†ãƒ¼ãƒã®é©ç”¨ï¼ˆè–¬å‰¤ã«å¿œã˜ã¦é¸æŠï¼‰ -->
<body class="endo-theme">  <!-- ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³: å†…åˆ†æ³Œç³»ãƒ†ãƒ¼ãƒ -->
<!-- ã¾ãŸã¯ -->
<body class="cardio-theme"> <!-- ãƒ†ãƒ«ãƒŸã‚µãƒ«ã‚¿ãƒ³: å¾ªç’°å™¨ç³»ãƒ†ãƒ¼ãƒ -->
<!-- ã¾ãŸã¯ -->  
<body class="cardio-theme"> <!-- ãƒ­ã‚¹ãƒã‚¹ã‚¿ãƒãƒ³: å¾ªç’°å™¨ç³»ãƒ†ãƒ¼ãƒ -->
```

#### 2. 3æ®µéšå­¦ç¿’ã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã®å®Ÿè£…ä¾‹
```html
<!-- è–¬å‰¤åè¡¨ç¤º -->
<h1 class="drug-name-display">ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³</h1>

<!-- ãƒ¬ãƒ™ãƒ«1ï¼ˆè–¬å­¦ç”Ÿå‘ã‘ï¼‰-->
<div class="level-1-content">
  <h3>è–¬å­¦ç”Ÿå‘ã‘: ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã®åŸºæœ¬</h3>
  <p>2å‹ç³–å°¿ç—…ã®ç¬¬ä¸€é¸æŠè–¬ã¨ã—ã¦æœ€ã‚‚é‡è¦ãªè–¬å‰¤ã§ã™...</p>
</div>

<div class="level-1-summary">
  <h4>30ç§’ã‚µãƒãƒªãƒ¼</h4>
  <p>ãƒ“ã‚°ã‚¢ãƒŠã‚¤ãƒ‰ç³»ã§å”¯ä¸€ç”Ÿãæ®‹ã£ãŸè–¬å‰¤...</p>
</div>

<div class="level-1-faq">
  <h4>è–¬å­¦ç”ŸFAQ</h4>
  <p><strong>Q:</strong> ãªãœãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã ã‘ãŒæ®‹ã£ãŸã®ï¼Ÿ</p>
  <p><strong>A:</strong> ä¹³é…¸ã‚¢ã‚·ãƒ‰ãƒ¼ã‚·ã‚¹ã®ãƒªã‚¹ã‚¯ãŒæœ€ã‚‚ä½ã„ãŸã‚...</p>
</div>

<!-- ãƒ¬ãƒ™ãƒ«2ï¼ˆå®Ÿç¿’ç”Ÿå‘ã‘ï¼‰-->
<div class="level-2-content">
  <h3>å®Ÿç¿’ç”Ÿå‘ã‘: å‡¦æ–¹ç®‹ã§ã®ãƒã‚§ãƒƒã‚¯ãƒã‚¤ãƒ³ãƒˆ</h3>
  <div class="practice-point">
    è…æ©Ÿèƒ½ç¢ºèªãŒå¿…é ˆï¼eGFR < 30ã§ä½¿ç”¨ç¦æ­¢
  </div>
  <div class="warning-note">
    âš ï¸ é€ å½±å‰¤ä½¿ç”¨å‰å¾Œã¯ä¸€æ™‚ä¼‘è–¬
  </div>
</div>

<div class="prescription-pattern">
  Rp. ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³éŒ 250mg  2éŒ 
      1æ—¥2å› æœå¤•é£Ÿå¾Œ   14æ—¥åˆ†
</div>

<!-- ãƒ¬ãƒ™ãƒ«3ï¼ˆç ”ä¿®åŒ»å‘ã‘ï¼‰-->
<div class="level-3-content">
  <h3>ç ”ä¿®åŒ»å‘ã‘: è‡¨åºŠã§ã®ä½¿ã„åˆ†ã‘</h3>
  <p>AMPKæ´»æ€§åŒ–ã«ã‚ˆã‚‹ç³–æ–°ç”ŸæŠ‘åˆ¶ã¨ã‚¤ãƒ³ã‚¹ãƒªãƒ³æ„Ÿå—æ€§æ”¹å–„...</p>
  <div class="expert-note">
    æ³¨ï¼šãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã®ä½œç”¨æ©Ÿåºã«ã¯è«¸èª¬ã‚ã‚‹
  </div>
</div>

<div class="clinical-evidence">
  <strong>UKPDSç ”ç©¶:</strong> è‚¥æº€2å‹ç³–å°¿ç—…æ‚£è€…ã§ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ãŒå¿ƒè¡€ç®¡æ­»ã‚’42%æ¸›å°‘...
</div>
```

#### 3. å€‹åˆ¥CSSåŸ‹ã‚è¾¼ã¿ã®å®Œå…¨å‰Šé™¤
```html
<!-- âŒ å‰Šé™¤å¯¾è±¡: å€‹åˆ¥CSSåŸ‹ã‚è¾¼ã¿ -->
<style>
/* 977è¡Œã®å€‹åˆ¥CSS - å®Œå…¨å‰Šé™¤ */
</style>

<!-- âœ… æ­£ã—ã„æ–¹æ³•: ver2-unified.cssæ´»ç”¨ -->
<link rel="stylesheet" href="../assets/css/ver2-unified.css">
```

---

## âœ… å“è³ªãƒã‚§ãƒƒã‚¯ãƒªã‚¹ãƒˆ

### å®Ÿè£…å‰ãƒã‚§ãƒƒã‚¯
- [ ] Ver2å°‚ç”¨CSSãƒ•ã‚¡ã‚¤ãƒ«ï¼ˆver2-unified.cssï¼‰ã®ä½œæˆ
- [ ] æ—¢å­˜CSSã¨ã®ç¶™æ‰¿é–¢ä¿‚ç¢ºèª
- [ ] 3æ®µéšå­¦ç¿’ãƒ¬ãƒ™ãƒ«ã®è¦–è¦šçš„å·®åˆ¥åŒ–ç¢ºèª

### å®Ÿè£…å¾Œãƒã‚§ãƒƒã‚¯
- [ ] å€‹åˆ¥CSSåŸ‹ã‚è¾¼ã¿ã®å®Œå…¨å‰Šé™¤
- [ ] 3æ®µéšã‚³ãƒ³ãƒ†ãƒ³ãƒ„ã®é©åˆ‡ãªè¦–è¦šçš„éšå±¤
- [ ] ãƒ¬ã‚¹ãƒãƒ³ã‚·ãƒ–å¯¾å¿œã®ç¢ºèª
- [ ] ã‚¢ã‚¯ã‚»ã‚·ãƒ“ãƒªãƒ†ã‚£ï¼ˆWCAG AAAï¼‰æº–æ‹ ç¢ºèª

### å“è³ªä¿è¨¼åŸºæº–
- **è¦–è¦šçš„ä¸€è²«æ€§**: å…¨ãƒ¬ãƒ™ãƒ«ã§çµ±ä¸€ã•ã‚ŒãŸãƒ‡ã‚¶ã‚¤ãƒ³è¨€èª
- **å­¦ç¿’åŠ¹æœ**: æ®µéšçš„ãªæƒ…å ±æç¤ºã«ã‚ˆã‚‹ç†è§£ä¿ƒé€²
- **æŠ€è¡“çš„å“è³ª**: ã‚¯ãƒªãƒ¼ãƒ³ãªCSSã€ä¿å®ˆæ€§ç¢ºä¿

---

## ğŸš€ å®Ÿè£…ãƒ­ãƒ¼ãƒ‰ãƒãƒƒãƒ—

### Phase 1: Ver2å°‚ç”¨CSSä½œæˆï¼ˆå®Ÿè¡Œäºˆå®šï¼‰
1. **Managerèª¿æŸ»çµæœçµ±åˆ**: æ—¢å­˜å¤‰æ•°æ´»ç”¨æ–¹é‡ç¢ºå®š
2. **ver2-unified.cssä½œæˆ**: çµ±ä¸€CSSãƒ•ã‚¡ã‚¤ãƒ«å®Ÿè£…
3. **å®Ÿè£…ä¾‹ä½œæˆ**: ãƒ¡ãƒˆãƒ›ãƒ«ãƒŸãƒ³ã§ã®é©ç”¨ä¾‹

### Phase 2: 3è–¬å‰¤ã¸ã®é©ç”¨ï¼ˆDeveloperå®Ÿè¡Œï¼‰
1. **metformin-v2.html**: å€‹åˆ¥CSSå‰Šé™¤ãƒ»çµ±ä¸€CSSé©ç”¨
2. **telmisartan-v2.html**: å€‹åˆ¥CSSå‰Šé™¤ãƒ»çµ±ä¸€CSSé©ç”¨  
3. **rosuvastatin-v2.html**: å€‹åˆ¥CSSå‰Šé™¤ãƒ»çµ±ä¸€CSSé©ç”¨

### Phase 3: å“è³ªç¢ºèªãƒ»æœ€é©åŒ–
1. **è¦–è¦šçš„çµ±ä¸€æ€§ç¢ºèª**: 3è–¬å‰¤ã®ä¸€è²«æ€§ãƒã‚§ãƒƒã‚¯
2. **å­¦ç¿’åŠ¹æœæ¤œè¨¼**: 3æ®µéšã‚·ã‚¹ãƒ†ãƒ ã®æ©Ÿèƒ½ç¢ºèª
3. **æŠ€è¡“å‚µå‹™æ ¹çµ¶ç¢ºèª**: å€‹åˆ¥CSSå®Œå…¨é™¤å»æ¤œè¨¼

---

## ğŸ“ˆ æœŸå¾…ã•ã‚Œã‚‹åŠ¹æœ

### å®šé‡çš„åŠ¹æœ
- **æŠ€è¡“å‚µå‹™å‰Šæ¸›**: 5000è¡Œè¶…â†’0è¡Œï¼ˆ100%å‰Šæ¸›ï¼‰
- **é–‹ç™ºæ™‚é–“çŸ­ç¸®**: CSSä½œæˆ1æ™‚é–“â†’é©ç”¨5åˆ†ï¼ˆ92%çŸ­ç¸®ï¼‰
- **ä¿å®ˆåŠ¹ç‡åŒ–**: ä¿®æ­£1ç®‡æ‰€â†’å…¨è–¬å‰¤åæ˜ ï¼ˆ95%åŠ¹ç‡åŒ–ï¼‰

### å®šæ€§çš„åŠ¹æœ
- **é–‹ç™ºè€…ä½“é¨“å‘ä¸Š**: æ˜ç¢ºãªæŒ‡é‡ã«ã‚ˆã‚‹æ··ä¹±è§£æ¶ˆ
- **å“è³ªçµ±ä¸€**: Ver2å…¨ä½“ã®è¦–è¦šçš„ä¸€è²«æ€§ç¢ºä¿
- **å­¦ç¿’åŠ¹æœæœ€å¤§åŒ–**: 3æ®µéšã‚·ã‚¹ãƒ†ãƒ ã®æŠ€è¡“çš„å®Ÿç¾

---

**æ¬¡ã®ã‚¢ã‚¯ã‚·ãƒ§ãƒ³**: Managerèª¿æŸ»çµæœã®çµ±åˆãƒ»å¤‰æ•°ãƒãƒƒãƒ”ãƒ³ã‚°è¡¨ã®å®Œæˆ
